Form 8-K - Current report:
SEC Accession No. 0001372514-24-000039
Filing Date
2024-05-03
Accepted
2024-05-02 17:56:53
Documents
14
Period of Report
2024-05-01
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kprx-20240501.htm   iXBRL 8-K 67156
2 EX-3.1 certificateofamendment.htm EX-3.1 7703
  Complete submission text file 0001372514-24-000039.txt   211002

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kprx-20240501.xsd EX-101.SCH 1919
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kprx-20240501_lab.xml EX-101.LAB 23451
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kprx-20240501_pre.xml EX-101.PRE 13593
17 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20240501_htm.xml XML 3018
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 24910086
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)